1.0Genekam Biotechnology AGhttps://genekam.deGenekamhttps://genekam.de/index.php/author/genekam/rich600338<blockquote class="wp-embedded-content" data-secret="QvlSFE6o0e"><a href="https://genekam.de/index.php/sars-hunter-therapy/">SARS-Hunter-Therapy</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://genekam.de/index.php/sars-hunter-therapy/embed/#?secret=QvlSFE6o0e" width="600" height="338" title="„SARS-Hunter-Therapy“ – Genekam Biotechnology AG" data-secret="QvlSFE6o0e" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://genekam.de/wp-includes/js/wp-embed.min.js /* ]]> */ </script> SARS Hunter Therapy option* Human polyclonal antibodies are being used as therapy for last century successfully and they are produced at industrial scale from different companies around the world. These pooled sera of many thousands of donors are being used to develop these polyclonal therapies, which are in a position to reduce many different infectionshttp://genekam.de/wp-content/uploads/2024/01/sarshunter.jpg